Weisbart R H, Bluestone R, Goldberg L S, Pearson C M
Proc Natl Acad Sci U S A. 1974 Mar;71(3):875-9. doi: 10.1073/pnas.71.3.875.
Production of human migration inhibitory factor by lymphocytes exposed to antigen was studied at intervals over a 7-day period. Migration inhibitory factor was measured by an agarose gel method, with buffycoat leukocytes as indicator cells. Lymphocyte supernatants from 7-day cultures consistently showed migration inhibitory factor activity; by contrast, enhancement of migration was frequently noted when effector cells were exposed to supernatants from 2- to 5-day cultures. Enhancement activity was manifested either by enhanced migration or by a sequential reduction in inhibitory activity consistent with a factor opposing the action of migration inhibitory factor. When supernatants were subjected to polyacrylamide gel electrophoresis, enhancement activity was regularly found in the beta-globulin region and migration inhibitory factor in the albumin fraction of the gel. The enhancement activity was heat-stable and nondialyzable. These findings characterize a hitherto unreported lymphokine, migration enhancement factor.
在7天的时间内,定期研究暴露于抗原的淋巴细胞产生人迁移抑制因子的情况。迁移抑制因子采用琼脂糖凝胶法,以血沉棕黄层白细胞作为指示细胞进行测定。来自7天培养物的淋巴细胞上清液始终显示出迁移抑制因子活性;相比之下,当效应细胞暴露于2至5天培养物的上清液时,经常会观察到迁移增强现象。增强活性表现为迁移增强或抑制活性的顺序降低,这与一种对抗迁移抑制因子作用的因子一致。当对上清液进行聚丙烯酰胺凝胶电泳时,增强活性通常出现在凝胶的β球蛋白区域,而迁移抑制因子出现在白蛋白部分。增强活性是热稳定的且不可透析。这些发现表征了一种迄今未报道的淋巴因子,即迁移增强因子。